Catalent, Inc.
CTLTNYSEHealthcare
$63.48
+$0.00(+0.00%)
Market Cap$11.5B
P/E Ratio—
52W High$63.5
52W Low$42.11
Catalent, Inc. (CTLT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CTLT · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2024Report Date: Nov 5, 2024EPS Actual
-$0.13
Est. -$0.03 · -340.7%
Revenue
$1.02B
Est. $1.06B · -3.3%
Fiscal Period
Q4 FY2024
FY ends December
Report Date
Nov 5, 2024
After Market Close
▼ Miss EPS▼ Miss Revenue
CTLT reports quarterly as a NYSE-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ▼ Q4 FY2024 | Nov 5, 2024 | -$0.03 | -$0.13 | -340.7% | $1.02B | $1.06B | -3.3% |
| ▲ Q3 FY2024 | Aug 29, 2024 | $0.47 | $0.65 | +39.3% | $1.30B | $1.22B | +6.3% |
| ▼ Q2 FY2024 | May 8, 2024 | $0.22 | -$0.06 | -127.9% | $1.07B | $1.12B | -4.3% |
| ▼ Q1 FY2024 | Feb 9, 2024 | -$0.02 | -$0.24 | -1055.5% | $1.02B | $1.12B | -8.4% |
| ▲ Q4 FY2023 | Nov 15, 2023 | -$0.13 | -$0.10 | +23.1% | $0.98B | $0.94B | +4.5% |
| ▼ Q3 FY2023 | Aug 29, 2023 | $0.10 | $0.09 | -10.0% | $1.07B | $1.05B | +1.4% |
| ▲ Q2 FY2023 | Jun 12, 2023 | -$0.13 | -$0.09 | +30.8% | $1.04B | $0.95B | +8.8% |
| ▼ Q1 FY2023 | Feb 7, 2023 | $0.72 | $0.67 | -6.9% | $1.15B | $1.12B | +2.2% |
Q4 FY2024
Nov 5, 2024Miss
EPS Actual
-$0.13
EPS Est.
-$0.03
EPS Surpr.
-340.7%
Revenue
$1.02B
Q3 FY2024
Aug 29, 2024Beat
EPS Actual
$0.65
EPS Est.
$0.47
EPS Surpr.
+39.3%
Revenue
$1.30B
Q2 FY2024
May 8, 2024Miss
EPS Actual
-$0.06
EPS Est.
$0.22
EPS Surpr.
-127.9%
Revenue
$1.07B
Q1 FY2024
Feb 9, 2024Miss
EPS Actual
-$0.24
EPS Est.
-$0.02
EPS Surpr.
-1055.5%
Revenue
$1.02B
Q4 FY2023
Nov 15, 2023Beat
EPS Actual
-$0.10
EPS Est.
-$0.13
EPS Surpr.
+23.1%
Revenue
$0.98B
Q3 FY2023
Aug 29, 2023Miss
EPS Actual
$0.09
EPS Est.
$0.10
EPS Surpr.
-10.0%
Revenue
$1.07B
Q2 FY2023
Jun 12, 2023Beat
EPS Actual
-$0.09
EPS Est.
-$0.13
EPS Surpr.
+30.8%
Revenue
$1.04B
Q1 FY2023
Feb 7, 2023Miss
EPS Actual
$0.67
EPS Est.
$0.72
EPS Surpr.
-6.9%
Revenue
$1.15B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2026 | $0.91 | $0.91 | $0.91 | 1 |
| Q1 FY2026 | $0.41 | $0.41 | $0.41 | 1 |
| Q4 FY2025 | $0.24 | $0.24 | $0.24 | 1 |
| Q3 FY2025 | $0.03 | $0.03 | $0.03 | 1 |
| Q2 FY2025 | $0.73 | $0.73 | $0.73 | 1 |
| Q1 FY2025 | $0.22 | $0.29 | $0.39 | 3 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2026 | $1.4B | $1.4B | $1.4B | 1 |
| Q1 FY2026 | $1.3B | $1.3B | $1.3B | 1 |
| Q4 FY2025 | $1.2B | $1.2B | $1.2B | 1 |
| Q3 FY2025 | $1.1B | $1.1B | $1.1B | 1 |
| Q2 FY2025 | $1.3B | $1.3B | $1.3B | 1 |
| Q1 FY2025 | $1.1B | $1.2B | $1.2B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q4 FY2024 | Nov 5, 2024 | -340.7% | $58.69 | $58.48 | -0.36% |
| ▲ Q3 FY2024 | Aug 29, 2024 | +39.3% | $59.80 | $60.95 | +1.92% |
| ▼ Q2 FY2024 | May 8, 2024 | -127.9% | $56.53 | $56.20 | -0.58% |
| ▼ Q1 FY2024 | Feb 9, 2024 | -1055.5% | $56.55 | $56.71 | +0.28% |
| ▲ Q4 FY2023 | Nov 15, 2023 | +23.1% | $35.53 | $39.56 | +11.34% |
| ▼ Q3 FY2023 | Aug 29, 2023 | -10.0% | $45.64 | $47.81 | +4.75% |
| ▲ Q2 FY2023 | Jun 12, 2023 | +30.8% | $38.81 | $42.78 | +10.23% |
| ▼ Q1 FY2023 | Feb 7, 2023 | -6.9% | $67.00 | $71.58 | +6.84% |
Q4 FY2024-0.36%
Report Date
Nov 5, 2024
EPS Beat/Miss
-340.7%
Price Before
$58.69
Price After
$58.48
Q3 FY2024+1.92%
Report Date
Aug 29, 2024
EPS Beat/Miss
+39.3%
Price Before
$59.80
Price After
$60.95
Q2 FY2024-0.58%
Report Date
May 8, 2024
EPS Beat/Miss
-127.9%
Price Before
$56.53
Price After
$56.20
Q1 FY2024+0.28%
Report Date
Feb 9, 2024
EPS Beat/Miss
-1055.5%
Price Before
$56.55
Price After
$56.71
Q4 FY2023+11.34%
Report Date
Nov 15, 2023
EPS Beat/Miss
+23.1%
Price Before
$35.53
Price After
$39.56
Q3 FY2023+4.75%
Report Date
Aug 29, 2023
EPS Beat/Miss
-10.0%
Price Before
$45.64
Price After
$47.81
Q2 FY2023+10.23%
Report Date
Jun 12, 2023
EPS Beat/Miss
+30.8%
Price Before
$38.81
Price After
$42.78
Q1 FY2023+6.84%
Report Date
Feb 7, 2023
EPS Beat/Miss
-6.9%
Price Before
$67.00
Price After
$71.58
Avg Beat Reaction+7.83%
Avg Miss Reaction+2.19%
Beat Rate3 / 8 quarters
Largest Move+11.34% (Q4 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CTLT ends December
Catalent, Inc. (CTLT) most recently reported earnings on November 5, 2024 for Q4 FY2024, posting EPS of $-0.13 — missing the analyst consensus of $-0.03 by -340.7%. The next CTLT earnings date is expected around September 1, 2026.
Each quarter, investors track CTLT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CTLT revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CTLT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CTLT earnings · 5 questionsCatalent, Inc.'s next earnings report is expected around September 1, 2026. CTLT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CTLT historically reports after market close (AMC).
CTLT earnings datewhen is CTLT earningsCTLT next earnings datewhen does CTLT report earningsCTLT earnings calendar
▸ Source: FMP · Catalent, Inc. SEC filings · US GAAP · Catalent, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026